139 related articles for article (PubMed ID: 12370063)
1. Strategies for access to enantiomerically pure ecadotril, dexecadotril and fasidotril: a review.
Monteil T; Danvy D; Sihel M; Leroux R; Plaquevent JC
Mini Rev Med Chem; 2002 Jun; 2(3):209-17. PubMed ID: 12370063
[TBL] [Abstract][Full Text] [Related]
2. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine-induced hypertension.
Takeda Y; Inaba S; Furukawa K; Fujimura A; Miyamori I; Mabuchi H
J Hypertens; 2000 Jul; 18(7):927-33. PubMed ID: 10930191
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.
Marie C; Mossiat C; Gros C; Schwartz JC; Lecomte JM; Bralet J
Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026
[TBL] [Abstract][Full Text] [Related]
5. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric syntheses and transformations--tools for chirality multiplication in drug synthesis.
Gawroński J
Acta Pol Pharm; 2006; 63(5):333-51. PubMed ID: 17357583
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans.
Laurent S; Boutouyrie P; Azizi M; Marie C; Gros C; Schwartz JC; Lecomte JM; Bralet J
Hypertension; 2000 May; 35(5):1148-53. PubMed ID: 10818079
[TBL] [Abstract][Full Text] [Related]
9. Acute, subchronic, and chronic toxicity of ecadotril in dogs.
Maertins T; von Keutz E; Goetze L
Am J Vet Res; 2000 Apr; 61(4):425-9. PubMed ID: 10772108
[TBL] [Abstract][Full Text] [Related]
10. Construction of Axially Chiral Compounds via Asymmetric Organocatalysis.
Wang YB; Tan B
Acc Chem Res; 2018 Feb; 51(2):534-547. PubMed ID: 29419282
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study.
O'Connor CM; Gattis WA; Gheorghiade M; Granger CB; Gilbert J; McKenney JM; Messineo FC; Burnett JC; Katz SD; Elkayam U; Kasper EK; Goldstein S; Cody RJ; Massie BM
Am Heart J; 1999 Dec; 138(6 Pt 1):1140-8. PubMed ID: 10577446
[TBL] [Abstract][Full Text] [Related]
12. Copper-catalyzed asymmetric allylic substitution of racemic/
Li J; Huang J; Wang Y; Liu Y; Zhu Y; You H; Chen FE
Chem Sci; 2024 Jun; 15(22):8280-8294. PubMed ID: 38846404
[TBL] [Abstract][Full Text] [Related]
13. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Chirally Pure Enantiomers by Lipase.
Bhardwaj KK; Gupta R
J Oleo Sci; 2017 Oct; 66(10):1073-1084. PubMed ID: 28924089
[TBL] [Abstract][Full Text] [Related]
15. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
16. The synthesis of isoquinoline alkaloid and its related compounds using alanine derivatives as chiral auxiliaries.
Itoh T; Nagata K; Yokoya M; Miyazaki M; Kameoka K; Nakamura S; Ohsawa A
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):951-5. PubMed ID: 12913234
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and enantioselectivity of the antiviral effects of (R,Z)-,(S,Z)-methylenecyclopropane analogues of purine nucleosides and phosphoralaninate prodrugs: influence of heterocyclic base, type of virus and host cells.
Qiu YL; Geiser F; Kira T; Gullen E; Cheng YC; Ptak RG; Breitenbach JM; Drach JC; Hartline CB; Kern ER; Zemlicka J
Antivir Chem Chemother; 2000 May; 11(3):191-202. PubMed ID: 10901290
[TBL] [Abstract][Full Text] [Related]
18. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Gros C; Noël N; Souque A; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Lecomte JM; Bralet J
Proc Natl Acad Sci U S A; 1991 May; 88(10):4210-4. PubMed ID: 1851998
[TBL] [Abstract][Full Text] [Related]
19. Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study Investigators.
Cleland JG; Swedberg K
Lancet; 1998 May; 351(9116):1657-8. PubMed ID: 9620738
[No Abstract] [Full Text] [Related]
20. Development of Synthetic Methodologies via Catalytic Enantioselective Synthesis of 3,3-Disubstituted Oxindoles.
Cao ZY; Zhou F; Zhou J
Acc Chem Res; 2018 Jun; 51(6):1443-1454. PubMed ID: 29808678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
